错义突变
TARDBP公司
肌萎缩侧索硬化
血管生长素
遗传学
突变
视神经肽
医学
单核苷酸多态性
SOD1
生物
基因
疾病
内科学
基因型
血管生成
作者
Zhang‐Yu Zou,Xinning Wang,Mingsheng Liu,Qin Sun,Xiaoguang Li,Liying Cui,Jiming Kong
标识
DOI:10.3109/17482968.2011.643900
摘要
Angiogenin (ANG) gene mutations have been identified in both familial and sporadic amyotrophic lateral sclerosis (ALS) patients from multiple European and North American populations. However, no ANG mutation has yet been reported in Asian ALS populations. Here, we screened for ANG mutations in a Chinese ALS cohort. The entire coding region of the ANG gene was sequenced in 10 familial ALS pedigrees, 202 sporadic ALS patients, and 151 healthy controls. All patients were negative for SOD1, FUS, and TARDBP mutations. We identified a novel missense mutation, c.379G > A (p.V103I), in one sporadic ALS patient, but not in the controls. No mutations were found in the familial ALS patients. A novel missense variant, c.323A > G (p.H84R), was detected in one healthy individual. We identified the presence of the known single nucleotide polymorphism, rs11701 (T/G), in both ALS cases and controls. However, no significant association of the G allele with ALS susceptibility was demonstrated. In conclusion, ANG mutations accounted for 0.5% of our SOD1-, FUS-, TARDBP- mutation-negative ALS cohort. Our findings highlight that the genetic background of ALS differs between different populations, and suggest that ANG mutation may be involved in the aetiology of ALS in the Han Chinese population.
科研通智能强力驱动
Strongly Powered by AbleSci AI